Aerie Pharmaceuticals Inc. (AERI) Leaped To A New High On Study Results

Aerie Pharmaceuticals Inc. (AERI) announced after the close Wednesday that its Phase 3 study of Roclatan achieved its primary efficacy endpoint.

from RTT - Before the Bell http://ift.tt/2roffZO
via IFTTT